Based on SEC filing data. A biotech corporation in South San Francisco raised $30.0M in an option round while in its growth stage.
Get notified the moment CytomX Therapeutics, Inc. (CTMX) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.